Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Caravan Biologix is focused on rare and hard treat human diseases. Our mission is to develop
state of the art therapeutics to make a genuine difference.
Mini-CAR BioNV Development Pipeline
Mini-CAR BioNVs offer unprecedented tumor penetration and killing power in the context of solid tumors such as Hepatocellular Carcinoma (HCC). These BioNVs, armed with CARs, can target HCC cells with remarkable specificity, reducing damage to healthy tissue while minimizing side effects.
Mini-CAR BioNVs hold promise for revolutionizing Systemic Lupus Erythematosus (SLE) treatment. These innovative nanovesicles can deliver targeted therapy, reducing off-target effects and enhancing efficacy with higher precision with the promise of better safety profiles than whole cell based approaches.
Mini-CAR BioNVs have exceptional promise in restoring Natural Killer (NK) cell function in Hemophagocytic Lymphohistiocytosis (HLH). These specialized BioNVs can precisely target and deliver therapeutic payloads to dysfunctional cells, enhancing their activity against the dysregulated immune responses seen in HLH.